Skip to content
healthcare.dev

Metolazone

NDC 51079-023, metolazone, tablet, from Mylan Institutional Inc..

Product NDC
51079-023
Status
Listed
Labeler
Mylan Institutional Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA076698
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51079-023 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • METOLAZONE2.5 mg/1

Pharmacologic classes

Increased Diuresis [PE]; Thiazide-like Diuretic [EPC]

Package NDCNDC-11Package
51079-023-2051079002320100 BLISTER PACK in 1 CARTON (51079-023-20) / 1 TABLET in 1 BLISTER PACK (51079-023-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e5fe856e-7fd6-47fb-87f7-7c1c621f50a0
  • NADAC price for package 51079002320

    GET /v1/drugs/nadac/51079002320

Use it

Look up 51079-023 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51079-023 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51079-023. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.